Teclistamab for patients with heavily pretreated relapsed or refractory multiple myeloma

E2108: Systemic therapy plus early local therapy versus systemic therapy alone in women with de novo stage IV breast cancer

KEYNOTE-604: Pembrolizumab plus etoposide and platinum as a first-line therapy for extensive-stage small-cell lung cancer

Clinical impact of COVID-19 on patients with cancer: Data from the COVID-19 and Cancer Consortium (CCC19)

Cumulative incidence of financial hardship in metastatic colorectal cancer patients: Primary endpoint results for SWOG S1417CD

Denosumab in multiple myeloma patients with renal insufficiency

Association of BRCA alterations with response to PARP inhibitors in metastatic castration-resistant prostate cancer

LuPSMA vs cabazitaxel in metastatic castration-resistant prostate cancer progressing after docetaxel

The paediatric precision oncology study INFORM: Clinical outcome and benefit for molecular subgroups

Maintenance avelumab plus best supportive care (BSC) versus BSC alone after chemotherapy in advanced urothelial carcinoma

Better genetic diagnostics in Ugandan breast cancer patients

Cisplatin plus/minus veliparib in metastatic TNBC and/or germline BRCA-associated breast cancer